Overview
ARQT market data
Price History
ARQT price chart · 1M
- O
- 29.15
- H
- 29.37
- L
- 28.16
- C
- 28.85
- Vol
- 99,827.00
Daily history from Jan 31, 2020
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $29.15
- Previous Close
- $29.08
- Day High
- $29.37
- Day Low
- $28.16
- 52 Week High
- $31.75
- 52 Week Low
- $19.30
- 7 Day Return
- +8.60%
- 30 Day Return
- +10.28%
- 90 Day Return
- +4.85%
- 1 Year Return
- +37.88%
- Daily Notional Volume
- $2.9M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 128.52 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.13 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.66 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 6.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $19.30 – $31.77 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- $37.00 Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.7B · P/B 18.77 · P/S 7.90.
Company News
10 captured
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall ClinicalGlobenewswire Inc ·
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globenewswire Inc ·